References
1. Y. Jin et al., "Self-Assembled Drug Delivery Systems-Properties and In Vitro –In Vivo Behaviour of Acyclovir Self-Assembled Nanoparticles (san)," Int. J. Pharm.
309 (1–2), 199–207 (2006).
2. P. Goyal et al., "Liposomal Drug Delivery Systems: Clinical Applications," Acta Pharm.
55, 1–25 (2005).
3. H.A. Lieberman, M.M. Rieger, and G.S. Banker, Pharmaceutical Dosage Forms: Disperse Systems (Informa Healthcare, London, England, 1998), p. 163.
4. S.S. Biju et al., "Vesicular Systems: An Overview," Ind. Jour. Pharm. Sci. 68 (2), 141–153 (2006).
5. M.O. Vaizoglu and P.P. Speiser, "Pharmacosomes—A Novel Drug Delivery System," Acta Pharm. Suec.
23, 163–172 (1986).
6. A. Singh and R. Jain, "Targeted Vesicular Constructs For Cytoprotection and Treatment of H. Pylori Infections," US Patent 6576,625 (2003).
7. I.P. Kaur and M. Kanwar, "Ocular Preparations: The Formulation Approach," Drug Dev. Ind. Pharm.
28 (5), 473–493 (2002).
8. F. Volkering et al., "Influence of Nonionic Surfactants on Bioavailability and Biodegradation of Polycyclic Aromatic Hydrocarbons,"
App. Environ. Micro.
61 (5), 1699–1705 (1995).
9. A. Steve, "Lipophilic Drug Derivatives For Use In Liposomes," US Patent 5534499 (1996).
10. I. Taskintuna et al., "Evaluation Of A Novel Lipid Prodrug for Intraocular Drug Delivery: Effect of Acyclovir Diphosphate
Dimyristoylglycerol in a Rabbit Model With Herpes Simplex Virus-1 Retinitis," Retin.
17 (1), 57–64, (1997).
11. M. J. Lawrence, "Surfactant Systems: Their Use in Drug Delivery," Chem. Soc. Rev.
23, 417–424 (1994).
12. C.C. Muller-Goymann and H.J. Hamann, "Pharmacosomes : Multilamellar Vesicles Consisting Of Pure Drug," Eur. J. Pharm. Biopharm.
37, 113–117 (1991).
13. J.S. Valentino and N.C. William, Lymphatic Transport of Drugs (CRC Press, Boca Raton, FL, 1992), pp. 205.
14. Z.R. Zhang, J.X. Wang, and J. Lu, "Optimization of the Preparation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine Pharmacosomes
Using Central Composite Design," Yao Xue Xue Bao
36 (6), 456–461 (2001).
15. Z.R. Zhang and J.X. Wang, "Study on Brain Targeting 3',5'-dioctanoyl-5-fluoro-2'-Deoxyuridine Pharmacosomes," Yao Xue Xue Bao.
36 (10), 771–776 (2001).
16. A. Ping, Y. Jin, and C. Da-wei, "Preparation and In Vivo Behavior of Didanosine Pharmacosomes in Rats," Chin. J. Pharm.
3, 227–235 (2005).
17. M. Gulati et al., "Lipophilic Drug Derivatives In Liposomes," Int. J. Pharm.
165, 129–168 (1998).
18. N.K. Jain, Advances In Controlled and Novel Drug Delivery ( CBS Publishers, New Delhi, India, 2003), p. 276.
19. S. Mantelli, P. Speiser, and H. Hauser, "Phase Behaviour of a Diglyceride Prodrug: Spontaneous Formation of Unilamellar
Vesicles," Chem. Phys. Lipid.
37 (4), 329–343 (1985).
|
